Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Vvi4g0033 | ATGTCGAAACCACTATTTTTATTTGCCAAAATTTCATTCCCCGCTCTGTTTCTCCTCCTAGTCCTCTTCTTACCCCTTCAAATAATTTCCCAAAATCTGCATGATGAACGATCAATCCTCCTAGACGTTAAACAACAACTGGGCAATCCACCGTCACTCCAATCGTGGAATTCTTCATCCTCGCCCTGTGATTGGCCGGAAATTACATGCACCAACAATACCATCATTGCAATTTCGCTCCACAATAAGACCATCAGAGAGAAAATTCCAGCCACAATTTGTGACCTCAAGAACCTCATCATACTTGACCTCTCCAACAATTACATTCCCGGTGAGTTCCCGGATATTCTCAATTGTTCCAAGCTTGAGTATCTGCTCTTGTTGCAAAACTCCTTCGTGGGTCCAATTCCAGCTGATATTGATCGACTTTCACGTCTTCGGTACCTAGACCTCACCGCAAACAATTTCTCTGGAGATATTCCTACAGCAATTGGGCGGCTACGGGAGCTGTTCTACTTGTTTTTGGTCCAAAACGAGTTCAACGGCACCTGGCCAAAGGAGATTGGTAATTTGGCGAATCTTGAACATTTGGTCATGGCCTATAATAACAAATTCCTGCCTTCAGCCCTTCCAAAGGAGTTTGGCGCATTGAAGAAGCTGAAGTATCTGTGGATGAAACAGGCGAATTTGATCGGGGAAATACCGGAGAGCTTCAACAATCTATGGAGTCTGGAACACTTGGATCTCTCACTCAACAAATTGGAAGGCACGATCCCAGGAGGCATGCTTATGTTGAAGAATTTGACTAATTTGTATTTATTCAATAATAGATTGTCCGGCCGCATTCCTATGACCATAGAAGCTCTCAACTTGAAAGAAATTGATCTTTCCAAGAACTATTTGACGGGGCCGATACCAACGGGTTTCGGGAAGCTACAAAATTTGACGAGTTTGAATCTTTTCTGGAATCAGTTGTCAGGAGAGATACCAGCAAATATAAGCCTCATTCCTACATTGGAAACCTTCAAAGTTTTTAGCAATCAATTGAGTGGAGTTTTGCCTCCAGCATTTGGCCTTCATTCGGAGCTCAAACGCTTTGAGGTTTCCGAGAATAAACTAAGCGGGAAATTACCTCAACATTTATGCGCAAGGGGGGCTTTGCTTGGAGTGGTTGTTTCCAACAACAATCTCAGCGGGGAAGTGCCCAAGTCCCTCGGGAATTGCACAAGTTTGCTCACAATTCAGCTTTCCAACAATTGCTTTTCAAGCGAGATTCCTTCCGGCATCTGGACATCCCCGGACATGGTATCGGTGATGTTATCTGGAAATTCATTCTCGGGGGCACTTCCAAGTAGATTGGCAAGGAATTTGTCCAGAGTGGATATCAGTAACAACAAGTTTTCTGGTCCAATTCCTGCTGAAATCTCTTCTTGGATGAACATAGGTGTGCTCATTGCCAACAACAATATGTTGTCAGGAAAAATTCCAGTGGAATTGACCAGTCTTTGGAACATCTCTATTCTGTTGCTTAACGGGAATCAATTCTCGGGTGAACTTCCATCCCAGATCATCTCATGGAAGTCACTCACTAATTTGAATCTCTCAAGAAACAAACTTTCAGGCCTAATTCCCAAGGCATTAGGTTCTTTAACTAGCCTTACTTACCTTGACCTGTCAGAAAACCAGTTCTCAGGTCAAATTCCTTCTGAACTTGGTCATTTGAAGCTTAATATCCTCGATCTTTCGTCCAACCAACTCTCTGGGATGGTCCCCATTGAGTTTCAATATGGAGGATATGAACACAGTTTCTTGAACAATCCCAAGCTGTGTGTCAATGTTGGCACTTTAAAACTCCCTAGATGTGATGTCAAAGTCGTTGACTCCGACAAATTGTCAACCAAATATCTCGTTATGATCCTAATTTTCGCTCTATCTGGTTTCCTAGTTGTTGTTTTCTTTACCCTGTTCATGGTTCGAGACTATCACAGGAAGAATCACAGTCGAGACCATACAACTTGGAAGCTTACTCGATTCCAAAATCTGGATTTCGATGAACATAACATATTGTCCGGTTTGACAGAAAATAATTTGATCGGACGTGGTGGGTCAGGGAAAGTATACCGAATTGCTAATAACCGTTCTGGTGAACTCCTAGCAGTTAAAAGGATTTGTAATAACAGGAGATTGGATCACAAGCTTCAGAAACAATTCATAGCAGAAGTCGAGATATTGGGCACCATACGCCATTCCAATATAGTGAAGTTGTTGTGCTGCATATCAAATGAAAGTTCAAGCCTTCTTGTTTATGAGTACATGGAGAGTCAGAGTTTGGATAGATGGCTTCATGGGAAGAAGCAGAGAACATCGTCCATGACAAGTTCAGTCCATAACTTTGTCTTGGATTGGCCAACAAGGTTGCAGATTGCCATCGGAGCTGCAAAAGGCCTACGCCACATGCATGAATACTGTTCTGCCCCGATCATACATCGAGATGTGAAGTCCAGCAACATCTTGCTAGATGCTGAGTTCAACGCGAAAATTGCGGATTTTGGATTGGCCAAGATGTTGGTCAAGCAAGGAGAGGCCGACACCATGTCAGGAATTGCAGGCTCTTACGGATATATTGCCCCTGAGTATGCTTATACAACAAAGGTGAACGAGAAGATCGATGTATATAGCTTTGGAGTAGTCTTGCTTGAGCTGGTGACGGGGAGAGAACCCAACAGCGGGAACGAGCACATGTGCCTTGTAGAATGGGCATGGGATCAGTTCAGAGAAGAGAAAACCATTGAGGAAGTGATGGATGAGGAGATCAAGGAAGAATGTGACACAGCACAAGTGACCACTCTCTTCACTCTAGGCCTCATGTGCACTACCACATTACCATCCACTAGGCCAACAATGAAAGAGGTTTTGGAAATTCTTCGACAGTGCAATCCTCAGGAGGGGCATGGAAGAAAGAAAAAGGACCATGAAGTTGCACCCCTACTTCAAAATGGCACTTACCCCGCTACTAACAAGCATAGCGACAAGGGATCAAACAATGAGGATGACGATGTACACCCCAGCTTCAAAATTTACCGCTTGTAA | 3090 | 0.4353 | MSKPLFLFAKISFPALFLLLVLFLPLQIISQNLHDERSILLDVKQQLGNPPSLQSWNSSSSPCDWPEITCTNNTIIAISLHNKTIREKIPATICDLKNLIILDLSNNYIPGEFPDILNCSKLEYLLLLQNSFVGPIPADIDRLSRLRYLDLTANNFSGDIPTAIGRLRELFYLFLVQNEFNGTWPKEIGNLANLEHLVMAYNNKFLPSALPKEFGALKKLKYLWMKQANLIGEIPESFNNLWSLEHLDLSLNKLEGTIPGGMLMLKNLTNLYLFNNRLSGRIPMTIEALNLKEIDLSKNYLTGPIPTGFGKLQNLTSLNLFWNQLSGEIPANISLIPTLETFKVFSNQLSGVLPPAFGLHSELKRFEVSENKLSGKLPQHLCARGALLGVVVSNNNLSGEVPKSLGNCTSLLTIQLSNNCFSSEIPSGIWTSPDMVSVMLSGNSFSGALPSRLARNLSRVDISNNKFSGPIPAEISSWMNIGVLIANNNMLSGKIPVELTSLWNISILLLNGNQFSGELPSQIISWKSLTNLNLSRNKLSGLIPKALGSLTSLTYLDLSENQFSGQIPSELGHLKLNILDLSSNQLSGMVPIEFQYGGYEHSFLNNPKLCVNVGTLKLPRCDVKVVDSDKLSTKYLVMILIFALSGFLVVVFFTLFMVRDYHRKNHSRDHTTWKLTRFQNLDFDEHNILSGLTENNLIGRGGSGKVYRIANNRSGELLAVKRICNNRRLDHKLQKQFIAEVEILGTIRHSNIVKLLCCISNESSSLLVYEYMESQSLDRWLHGKKQRTSSMTSSVHNFVLDWPTRLQIAIGAAKGLRHMHEYCSAPIIHRDVKSSNILLDAEFNAKIADFGLAKMLVKQGEADTMSGIAGSYGYIAPEYAYTTKVNEKIDVYSFGVVLLELVTGREPNSGNEHMCLVEWAWDQFREEKTIEEVMDEEIKEECDTAQVTTLFTLGLMCTTTLPSTRPTMKEVLEILRQCNPQEGHGRKKKDHEVAPLLQNGTYPATNKHSDKGSNNEDDDVHPSFKIYRL* | 1030 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Vvi4g0033 | 1029 | SMART | serkin_6 | 692 | 974 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vvi4g0033 | 1029 | MobiDBLite | consensus disorder prediction | 999 | 1029 | - | - | |
Vvi4g0033 | 1029 | Gene3D | Ribonuclease Inhibitor | 27 | 84 | IPR032675 | - | |
Vvi4g0033 | 1029 | Gene3D | Ribonuclease Inhibitor | 85 | 288 | IPR032675 | - | |
Vvi4g0033 | 1029 | ProSitePatterns | Protein kinases ATP-binding region signature. | 698 | 721 | IPR017441 | GO:0005524 | |
Vvi4g0033 | 1029 | ProSiteProfiles | Leucine-rich repeat profile. | 575 | 596 | IPR001611 | GO:0005515 | |
Vvi4g0033 | 1029 | Gene3D | Ribonuclease Inhibitor | 289 | 385 | IPR032675 | - | |
Vvi4g0033 | 1029 | PANTHER | OS04G0122200 PROTEIN | 46 | 186 | - | - | |
Vvi4g0033 | 1029 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 827 | 839 | IPR008271 | GO:0004672|GO:0006468 | |
Vvi4g0033 | 1029 | MobiDBLite | consensus disorder prediction | 1010 | 1029 | - | - | |
Vvi4g0033 | 1029 | FunFam | Receptor-like protein kinase HSL1 | 672 | 771 | - | - | |
Vvi4g0033 | 1029 | SUPERFAMILY | L domain-like | 374 | 594 | - | - | |
Vvi4g0033 | 1029 | Pfam | Leucine rich repeat N-terminal domain | 35 | 70 | IPR013210 | - | |
Vvi4g0033 | 1029 | SMART | LRR_typ_2 | 143 | 167 | IPR003591 | - | |
Vvi4g0033 | 1029 | SMART | LRR_typ_2 | 526 | 549 | IPR003591 | - | |
Vvi4g0033 | 1029 | SMART | LRR_typ_2 | 408 | 432 | IPR003591 | - | |
Vvi4g0033 | 1029 | SMART | LRR_typ_2 | 96 | 119 | IPR003591 | - | |
Vvi4g0033 | 1029 | SMART | LRR_typ_2 | 241 | 265 | IPR003591 | - | |
Vvi4g0033 | 1029 | SMART | LRR_typ_2 | 550 | 574 | IPR003591 | - | |
Vvi4g0033 | 1029 | SMART | LRR_typ_2 | 312 | 336 | IPR003591 | - | |
Vvi4g0033 | 1029 | SUPERFAMILY | L domain-like | 44 | 378 | - | - | |
Vvi4g0033 | 1029 | Gene3D | Ribonuclease Inhibitor | 386 | 625 | IPR032675 | - | |
Vvi4g0033 | 1029 | Gene3D | Transferase(Phosphotransferase) domain 1 | 772 | 1001 | - | - | |
Vvi4g0033 | 1029 | ProSiteProfiles | Protein kinase domain profile. | 692 | 982 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vvi4g0033 | 1029 | Pfam | Leucine rich repeat | 528 | 586 | IPR001611 | GO:0005515 | |
Vvi4g0033 | 1029 | Pfam | Protein kinase domain | 694 | 973 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vvi4g0033 | 1029 | SUPERFAMILY | Protein kinase-like (PK-like) | 682 | 975 | IPR011009 | - | |
Vvi4g0033 | 1029 | FunFam | Kinase family with leucine-rich repeat domain-containing protein | 772 | 992 | - | - | |
Vvi4g0033 | 1029 | FunFam | Receptor-like protein kinase HSL1 | 33 | 187 | - | - | |
Vvi4g0033 | 1029 | Gene3D | Phosphorylase Kinase; domain 1 | 675 | 771 | - | - | |
Vvi4g0033 | 1029 | FunFam | Uncharacterized protein | 334 | 624 | - | - | |
Vvi4g0033 | 1029 | FunFam | Uncharacterized protein | 209 | 288 | - | - | |
Vvi4g0033 | 1029 | Pfam | Leucine Rich repeat | 312 | 328 | IPR001611 | GO:0005515 |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Vvi4g0033 | Vvi-Chr4 | 397192 | 400374 | Dispersed/Tandem |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Vvi4g0033 | 24 | 1020 | Receptor kinase-like Gene Family | AT5G25930 | 55.045 | 0.0 | 1050 |
Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
---|---|---|---|---|---|---|---|
PK | RLK-Pelle_LRR-XI-1 | Vvi4g0033 | Pkinase | 3e-49 | CL0016 |
Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
---|---|---|---|---|---|---|
Vvi4g0033 | K00924 | - | vvi:104878975 | 2030.76 |